REGN icon

Regeneron Pharmaceuticals

637 hedge funds and large institutions have $26.9B invested in Regeneron Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 238 increasing their positions, 200 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

1.59% less ownership

Funds ownership: 69.35%67.76% (-1.6%)

17% less capital invested

Capital invested by funds: $32.3B → $26.9B (-$5.46B)

31% less funds holding in top 10

Funds holding in top 10: 1611 (-5)

Holders
637
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.23B
Puts
$1.26B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$218M
27
$208M
28
$202M
29
$201M
30
$188M
31
$186M
32
$181M
33
$180M
34
$171M
35
$151M
36
$143M
37
$136M
38
$129M
39
$129M
40
$122M
41
$112M
42
$109M
43
$109M
44
$107M
45
$93.6M
46
$93.2M
47
$92M
48
$86.9M
49
$85.7M
50
$85.3M